Presales slowdown and litigation risk cloud margin strength

Brigade reported a blowout quarter on paper—profit up 37%, margins expanding 800 basis points. But dig into the delivery. Residential sales fell 5%. And that reported PAT bump is 83% accounted for by a one-time Bain Capital reclassification gain. The adjusted profit growth is closer to 14%. That gap between headline and organic is the quarter's real story.

Of the 37.3% YoY PAT growth, ₹36.6 crore was a non-cash exceptional gain from a Bain Capital investment reclassification at the subsidiary level. Strip that out, and underlying profit grew roughly 14%—solid, but far from the headline impression. The margin expansion, however, is real: RE EBITDA margin jumped to 21% from 12%, driven by recognition of higher-pedigree sold inventory from three to four years prior. New launches are expected to sustain these margins, though the CFO flagged a 5–6% contribution margin uplift already cycled through; the inventory pool can't repeat this gift.

Brigade cut its launch guidance from 11.5 million sq. ft. to 9.36 million for the full pipeline. Of that, 0.7 million sq. ft. (₹650 crore value) is Morgan Heights—sidelined by litigation. Another 1 million sq. ft. was attributed to a 'sales phasing methodology refinement,' suggesting prior guidance was loose. Despite the pipeline cut, presales guidance was held at ₹9,000 crore, a high-wire act requiring Q2–Q4 to deliver what Q1 fell short of. RE EBITDA margin guidance was raised from 'late teens' to 'into 20s' by year-end. Commercial leasing took a hit: WTC Bangalore's 0.375 million sq. ft. vacancy and disappearance of large RFPs forced a pivot to smaller 20–40 thousand sq. ft. modules; management now expects 3–4 quarters to close leasing, extended from prior near-term. Hospitality saw Four Points Kochi rebranding to Courtyard Marriott, causing a Q1 occupancy blip but expected to deliver 15–20% ADR uplift by year-end.

The post-result tape tells the story. Day 1 saw a muted +0.42% pop (only 53% delivery—weak conviction); by day 3 it faded to −0.19%. That's resignation, not enthusiasm. The stock sits at ₹625.75, down 22% from its all-time high yet above its 20-, 50-, and 200-day moving averages. RSI at 68 is neutral. The real tell is FII behavior: foreign institutions trimmed to 15.63% from 16.75% a year ago (−112 basis points), while domestic institutions nibbled up from 24.74% to 25.47%. FIIs are selling into strength; domestic money is opportunistically buying. That divergence signals institutions see execution risk the market isn't fully pricing. At ₹625.75, the stock prices in continued presales momentum and clean litigation outcomes—both now in doubt.